Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Enveda Biosciences

Biotech & Life Sciences · Boulder, United States · Founded 2019 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Headcount
100–500
Current team size
Unlock exact value

Investors

26 investors on Enveda Biosciences's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 4 investors entered at this stage
Village Global
Wireframe Ventures
True Ventures
Chris Gibson
Series A 6 investors entered at this stage
Matthew De Silva
Lux Capital
Two Sigma Ventures
Hummingbird Ventures
Catalio Capital Management
Lifeforce Capital
Series B+ 16 investors entered at this stage
FPV Ventures
Premji Invest
Amino Collective
IA Ventures
Henry Kravis
Kinnevik
Microsoft
Dimension
Baillie Gifford
Peakline Partners
Lingotto Investment Management
JAZZ Venture Partners
The Nature Conservancy
Level Ventures
Socium Ventures
Sanofi

Global footprint

Where Enveda Biosciences has talent and traffic

AI talent share
4.5% of workforce is AI talent
(17 of 376 staff)
Core AI102.66%
Other AI71.86%
Non-AI workforce35995.48%
Web traffic by country
26K monthly visits
across markets
🇺🇸 United States75.8%
🇮🇳 India14.2%
🇬🇧 United Kingdom5%
🇪🇸 Spain4.2%
🇨🇿 Czech Republic0.8%
Top 5 markets shown

Patent intelligence

$141k patent portfolio · 8 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$141k
0.01% of valuation · 2326.1× smaller than top peer Genmab ($328M)
8 active patent families
Where Enveda Biosciences innovates Mass Spectrometry-Mass SpectrometryMolecular biologyPharmacologyDiseasePerylene derivatives
Below peer median on Legal, Strategic, Market, Economic, Technology

Quality vs same-sector peers

Enveda Biosciences on the five Patsnap quality dimensions

Enveda Biosciences in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Enveda Biosciences concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Enveda Biosciences and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Enveda Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo